NCCN Breast Cancer Guidelines Update

Download Podcast

Listen to MP3

Podcast Evaluation

A presentation from the NCCN 13^th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida.

Presenters

Robert W. Carlson, MD
Stanford Comprehensive Cancer Center
Stanford, California

Stephen B. Edge, MD
Roswell Park Cancer Institute
Buffalo, New York

Faculty Disclosure Statements

Robert W. Carlson, MD

Dr. Carlson has disclosed that he has financial interests, arrangements, or affiliations with the manufacturer of products or devices to be discussed in this activity or who may financially support the educational activity.  He has served as a paid consultant for AstraZeneca Pharmaceuticals LP, Genomic Health, Inc., and Pfizer Inc.  He has served as a researcher for AstraZeneca Pharmaceuticals LP and Genentech, Inc.

Dr. Carlson has indicated that his presentation will not include discussion of investigational or unlabeled uses of a product.

Stephen B. Edge, MD

Dr. Edge has disclosed that he has no financial interests, arrangements, or affiliations with the manufacturer of products or devices to be discussed in this activity or who may financially support the educational activity. 

Dr. Edge has indicated that his presentation will not include discussion of investigational or unlabeled uses of a product.
                                   
Program Goal

The goal of this program is to provide participants with increased knowledge regarding the management of patients with breast cancer and discuss the innovative therapies and treatment methods.

Educational Objectives

Following this activity, participants should be able to:

• Discuss updates to NCCN guidelines for breast cancer
• Explain how these updates will impact the management of breast cancer

Intended Audience

This educational activity is designed to meet the educational needs of physicians, nurses, and other clinical professionals who manage patients with cancer.

Activity Instructions

Continuing education credit will be awarded to participants who listen to the presentation and complete the evaluation.  Participants should review the learning objectives and faculty disclosure statements prior to listening to a presentation in its entirety.  You must be connected to the Internet in order to review and complete the evaluation form.  A statement of credit will be electronically generated once you complete the evaluation form.  To receive credit, this activity must be completed no later than May 14, 2009.  There is no fee for participating in this activity.

Download Podcast

Listen to MP3

Podcast Evaluation

Accreditation Information

Physicians

The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NCCN designates this educational activity for a maximum of 0.75 AMA PRA Category 1
Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses

This activity is approved for 0.7 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Release date:  May 14, 2008
Expiration date:  May 14, 2009

Commercial Support

Supported by educational grants from AstraZeneca, Abraxis Bioscience, Genentech BioOncology, and GlaxoSmithKline Oncology